Brief: Moberg Pharma Q3 EBITDA Loss Narrows To SEK 4.0 Million
Nov 9 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* Q3 EBITDA LOSS SEK 4.0 MILLION VERSUS LOSS SEK 4.6
MILLION YEAR
AGO
Source text for Eikon: ID:nWkr78jk3x
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains